Evidence map›Paper›PMID 40166300›Full record

ArticlebioRxiv : the preprint server for biology2025

Prior epigenetic status predicts future susceptibility to seizures in mice.

Benjamin D Boros, Mariam A Gachechiladze, Juanru Guo, Dylan A Galloway, Shayna M Mueller, Mark Shabsovich, Allen Yen, Alexander J Cammack, Tao Shen, Robi D Mitra and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Benjamin D BorosDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0003-2708-4112
Mariam A GachechiladzeDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0003-0004-425X
Juanru GuoDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110.
Dylan A GallowayDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Shayna M MuellerDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110.
Mark ShabsovichDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Allen YenDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110.
Alexander J CammackDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Tao ShenDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Robi D MitraDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-2680-4264
Joseph D DoughertyDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-6385-3997
Timothy M MillerDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110.

Funding

Molecular recording to predict cell fate decisions and animal behaviorRF1MH126723 · NIMH · WASHINGTON UNIVERSITY · PI DOUGHERTY, JOSEPH D, MITRA, ROBI D · 2021 to 2021
$3.7M
PARALLEL ANALYSIS OF TRANSCRIPTION AND PROTEIN-DNAINTERACTIONS IN SINGLE CNS CELLSRF1MH117070 · NIMH · WASHINGTON UNIVERSITY · PI DOUGHERTY, JOSEPH D, MITRA, ROBI D · 2018 to 2020
$3.2M
Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancerR01DE032865 · NIDCR · WASHINGTON UNIVERSITY · PI Robi D Mitra, Sidharth Venkata Puram · 2023 to 2026
$2.4M
Boosting protein synthesis using antisense oligonucleotides to treat neurodegenerationF30AG082394 · NIA · WASHINGTON UNIVERSITY · PI Ben David Boros · 2024 to 2026
$125k
Antisense oligonucleotide-based upregulation of neurodevelopmental disorder gene MYT1LF30MH136688 · NIMH · WASHINGTON UNIVERSITY · PI GACHECHILADZE, MARIAM ALEXANDRA · 2024 to 2025
$72k
NIA NIH HHS F30 AG082394NIDCR NIH HHS R01 DE032865NIMH NIH HHS F30 MH136688NIMH NIH HHS RF1 MH117070NIMH NIH HHS RF1 MH126723
6 · The paper itself

Abstract

Wide variation of responses to identical stimuli presented to genetically inbred mice suggests the hypothesis that stochastic epigenetic variation during neurodevelopment can mediate such phenotypic differences. However, this hypothesis is largely untested since capturing pre-existing molecular states requires non-destructive, longitudinal recording. Therefore, we tested the potential of Calling Cards (CC) to record transient neuronal enhancer activity during postnatal development, and thereby associate epigenetic variation with a subsequent phenotypic presentation - degree of seizure response to the pro-convulsant pentylenetetrazol. We show that recorded differences in epigenetics at 243 loci predict a severe vs. mild response, and that these are enriched near genes associated with human epilepsy. We also validated pharmacologically a seizure-modifying role for two novel genes,

Identifiers

PMID40166300
PMCPMC11957114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.